Table 4.
The difference of PODXL expression in cancers and corresponding normal tissues in TCGA datasets
| Types of cancer | TCGA dataset | No. of cancer tissues | No. of normal tissues | Log2(FC) | P value |
|---|---|---|---|---|---|
| Adenoid cystic carcinoma | ACC | 77 | 128 | − 1.068 | 1.10e-10 |
| Breast invasion carcinoma | BRCA | 1085 | 291 | −0.514 | 4.01e-16 |
| Cervical squamous cell carcinoma | CESC | 306 | 13 | −0.590 | 0.191 |
| Esophagus cancer | ESCA | 182 | 286 | 1.391 | 5.97e-22 |
| Glioblastoma multiforme | GBM | 163 | 207 | 0.866 | 1.12e-10 |
| Head and neck squamous cell carcinoma | HNSCC | 519 | 44 | 0.656 | 0.123 |
| Kidney chromophobe | KICH | 66 | 53 | −2.863 | 1.53e-10 |
| Kidney renal clear cell carcinoma | KIRC | 523 | 100 | −0.732 | 1.85e-9 |
| Kidney renal papillary cell carcinoma | KIRP | 286 | 60 | −4.247 | 1.31e-43 |
| Acute myeloid leukemia | LAML | 173 | 70 | 1.210 | 3.26e-2 |
| Liver hepatocellular carcinoma | LIHC | 369 | 160 | 1.508 | 8.20e-32 |
| Lung adenocarcinoma | LUAD | 483 | 347 | −2.064 | 6.27e-122 |
| Lung squamous cell carcinoma | LUSC | 486 | 338 | −2.832 | 3.86e-153 |
| Ovarian serous cystadenocarcinoma | OVSC | 426 | 88 | 1.449 | 3.96e-14 |
| Pancreatic adenocarcinoma | PAAD | 179 | 171 | 0.492 | 4.05e-5 |
| Prostate carcinoma | PRAD | 492 | 152 | −0.479 | 0.044 |
| Rectum adenocarcinoma | READ | 92 | 318 | 0.598 | 8.17e-8 |
| Skin cutaneous melanoma | SKCM | 461 | 558 | −0.636 | 3.83e-6 |
| Stomach adenocarcinoma | STAD | 408 | 211 | 1.597 | 1.64e-49 |
| Testicular germ cell tumor | TGCT | 137 | 165 | 2.750 | 3.93e-30 |
| Thyroid carcinoma | THCA | 512 | 337 | −0.796 | 6.95e-22 |
| Uterine corpus endometrial carcinoma | UCEC | 174 | 91 | −0.797 | 2.97e-5 |
| Uterine carcinosarcoma | UCS | 58 | 78 | −2.075 | 3.79e-12 |